Γιαμούζης Γρηγόριος

Θέση: Επ.Καθηγητής Καρδιολογίας Πανεπιστημίου Θεσσαλίας
Κατηγορία: Διδάσκοντες, Επ. Καθηγητές/τριες

E D U C A T I O N

  • February 2013 – currently

University of Thessaly, Medical School and Deartment of Cardiology, University Hospital of Larissa, Larissa, Greece

Assistant Professor of Cardiology

  • January 2009 – February 2013

University of Thessaly, Medical School and Department of Cardiology, University Hospital of Larissa, Larissa, Greece

Lecturer in Cardiology

  • September 2007 – December 2008

Emory University Hospital, Atlanta, Georgia, USA

Faculty staff in the Heart Failure and Transplantation Clinic

  • November 2006 – September 2007

Emory University Hospital, Atlanta, Georgia, USA

Research fellowship in the Heart Failure and Transplantation Clinic

  • September 2003- September 2007

Onassis Cardiac Surgery Center, University Hospital, Athens, Greece

Fellowship in Cardiology • 15 months of clinical cardiology • 6 months of ICU/ER • 12 months of interventional cardiology (performed: 300 coronary angiograms, 250 PTCAs) • 6 months of echocardiography • 3 months of exercise training

  • July 2003 – July 2007

University of Thessaly, Medical School, Larisa, Greece

Greek PhD thesis entitled: “Acute hemodynamic effects of moderate doses of nebivolol versus metoprolol in patients with systolic heart failure”

  • 1992-1998

Aristotles University of Thessaloniki, Medical School, Greece

Medical School (6 years); grade, 7.97 out of 10 (13th among 556 medical students)

  • 1985-1991

3rd Volos High Scholl, Greece

June 1991, Greek Apolytirion; Grade, 19.9 out of 20 (1st among180 students)

P R O F E S S I O N A L E X P E R I E N C E

  • February 2013 – currently

University of Thessaly, Medical School and Department of Cardiology, University Hospital of Larissa, Larissa, Greece

Assistant Professor of Cardiology

  • December 2008 – currently

University of Thessaly, Medical School and Department of Cardiology, University Hospital of Larissa, Larissa, Greece

Lecturer of Cardiology

  • September 2007 – December 2008

Emory University Hospital, Atlanta, Georgia, USA

Faculty staff in the Heart Failure and Transplantation Clinic

  • November 2006 – September 2007

Emory University Hospital, Atlanta, Georgia, USA

Research fellowship in the Heart Failure and Transplantation Clinic

  • September 2003 – November 2006

Onassis Cardiac Surgery Center, University Hospital, Athens, Greece

Cardiology fellowship

  • September 2001 – August 2003

Achillopouleon General Hospital, Volos, Greece

Residency in internal medicine

  • January 2000 – September 2001

251 Hellenic Airforce Generall Hospital, Athens, Greece and 111th Hellenic Airforce Airport Medical Department, Nea Aghiallos, Greece

Military service for the Greek Army • Senior house officer, internal medicine

  • December 1998 – December 1999 Almyros District General Hospital, Greece Rural practice as a house officer
  • September 1998 – December 1998

Achillopouleon General Hospital, Volos, Greece

House officer, trimester in internal medicine and cardiology

R E S E A R C H E X P E R I E N C E

  • August 2014 – currently

Department of Cardiology, University Hospital of Larissa, Larissa, Greece

Principal investigator for the (PARAGON-HF) study: Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction. ClinicalTrials.gov Identifier: NCT01920711

  • January 2014 – currently

Department of Cardiology, University Hospital of Larissa, Larissa, Greece

Co-investigator for the Relaxin in Acute Heart Failure II (RELAX-AHF II) study, a randomized, placebo controlled, multicenter study of the effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients (RELAX-AHF-EU). ClinicalTrials.gov Identifier: NCT02064868

  • January 2011 – December 2014

Department of Cardiology, University Hospital of Larissa, Larissa, Greece

Principal investigator for the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) study, a randomized, placebo controlled, multicenter study of the efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion on outcome of hospitalized patients with acute heart failure. ClinicalTrials.gov Identifier: NCT00937092 (http://clinicaltrials.gov/ct2/show/NCT00937092)

  • January 2011 – currently

Department of Cardiology, University Hospital of Larissa, Larissa, Greece

Principal investigator for the Renewing Health Study, a randomized controlled study of telemonitoring in patients with chronic heart failure, sponsored by the European Union.

  • January 2009 – December 2011

Department of Cardiology, University Hospital of Larissa, Larissa, Greece

Principal investigator for the Dopamine in Acute Decompensated Heart Failure (DAD-HF) study, a randomized, placebo controlled study of the impact of dopamine infusion on renal function in hospitalized patients with acute heart failure. ClinicalTrials.gov Identifier: NCT00937092 (http://clinicaltrials.gov/ct2/show/NCT00937092)

  • October 2007 – current

Emory University Hospital, Atlanta, Georgia, USA

Study Director of The Atlanta Cardiomyopathy Consortium (TACC) trial, a large prospective trial for the natural history and genetic origin of Heart Failure, sponsored by a $2.2 million internal grant of the Emory University School of Medicine (ClinicalTrials.gov Identifier: NCT00599014), web page: http://clinicaltrials.gov/ct2/show/NCT00599014?spons=%22Emory+University%22&spons_ex=Y

  • September 2007 – current

Emory University Hospital, Atlanta, Georgia, USA

Co-investigator of the study: “NP-CPX study: kinetics of Natriuretic Peptides during Cardiopulmonary Exercise Testing and Heart Failure Outcomes”, sponsored by a $200,000 internal grant from the Cardiovascular Board of the Emory University School of Medicine

  • September 2007 – current

Emory University Hospital, Atlanta, Georgia, USA

Co-investigator of the study: “BIO-TACC: Serial measurement of novel biomarkers and heart failure outcomes: a TACC sub-study”, sponsored by a $180,000 internal grant from the Cardiovascular Board of the Emory University School of Medicine

  • May 2007 – current

Emory University Hospital, Atlanta, Georgia, USA

Co-investigator of the study: “HF-OUTS study: the Heart Failure Outcomes Study”, sponsored by the Emory University School of Medicine

  • March 2007 – current

Emory University Hospital, Atlanta, Georgia, USA

Co-investigator of the SONIHA-study: “The study of accuracy and predictive capability of biomarker based non-invasive hemodynamic assessment”, sponsored by the Emory University School of Medicine

  • December 2006 – current

Emory University Hospital, Atlanta, Georgia, USA

Principal Investigator of the study: “Prognosis and Outcomes Determination in Heart Failure”, sponsored by the Emory University School of Medicine

  • November 2006 – current

Emory University Hospital, Atlanta, Georgia, USA

Research fellowship in heart failure and heart transplantation

  • October 2004 – November 2006

Onassis Cardiac Surgery Center, Athens, Greece

Member of the hospital’s working group on Endothelial Progenitor Cells (EPCs) in acute myocardial infarction, dilated cardiomyopathy, idiopathic pulmonary arterial hypertension, patients receiving a ventricular assist device, and in heart transplant patients

  • February 2004 – March 2005

Onassis Cardiac Surgery Center, Athens, Greece

Co-investigator in the EuroHeart Survey for Chronic Heart Failure

  • September 2004 – September 2005

Onassis Cardiac Surgery Center, Athens, Greece

Co-investigator in the EuroHeart Survey for Atrial Fibrillation

  • September 2003 – current

Onassis Cardiac Surgery Center, Athens, Greece

Member of the hospital’s Heart Failure working group

  • July 2005 – current

Onassis Cardiac Surgery Center, Athens, Greece

Member of the editorial board of the Onassis Cardiac Surgery Center international medical journal “Cardia”

D I S T I N C T I O N S – S C H O L A R S H I P S

  • MATHEMATICS

Athens, Greece, 1989

2nd prize in Greek National Mathematics Competition

  • FREE DRAW

Volos, Greece, 1989

1st prize in high school`s local competition

  • PHYSICS

Athens, Greece, 1991

3rd prize in Greek National Physics Competition, qualified as member of the National Greek team for the 1991 Junior World Physics competition, Havana, Cuba (did not participate due to embargo)

  • MEDICINE

Athens, Greece, 2001

1st European Congress of Air and Space Medicine: 1st prize for the best scientific presentation

  • MEDICINE

Montreal, Canada, 2002

73rd AsMA Annual Scientific Meeting: Young Investigators Award Competition (10th out of 143 presentations)

  • MEDICINE

Athens, Greece, September 2006

Onassis Cardiac Surgery Center medical scholarship for a 6-month fellowship in cardiology in USA

  • MEDICINE

Athens, Greece, 2006

Alexandros Onassis Foundation annual medical scholarship, for 18-month fellowship in cardiology in USA

  • MEDICINE

Atlanta, Georgia, USA, 2006

Emory University scholarship for research in heart failure

  • MEDICINE

Athens, Greece, 2009

3rd prize for the best oral presentation, 12th Panhellenic Congress in Heart Failure, sponsored by the Hellenic Society of Cardiology

  • MEDICINE

Athens, Greece, 2011

1st prize for the best innovative prospective study (DAD-HF trial), 1st Christos Lambrakis Prize, Biomedical Research Foundation Academy of Athens.

M E M B E R O F S O C I E T I E S

  • Hellenic Medical Society (1998 – current)
  • Athens Medical Association (2003 – 2007)
  • Larissa Medical Association (2003 – current)
  • Hellenic Cardiologic Society (2007 – current)
  • Heart Failure Association of the European Society of Cardiology (2008 – current)

P E E R R E V I E W E D J O U R N A L P U B L I C A T I O N S

  1. Farmakis D, Stafylas P, Giamouzis G, Maniadakis N, Parissis J. The medical and socioeconomic burden of heart failure: A comparative delineation with cancer. International journal of cardiology. 2015. In press. doi:10.1016/j.ijcard.2015.10.172
  2. Ventoulis I, Mantziari L, Mouratoglou SA, Kamperidis V, Giannakoulas G, Ziakas A, Tsalikakis D, Giamouzis G, Hitoglou-Makedou A, Karvounis H. Ngal and st2 levels in ambulatory patients with chronic heart failure. Clinical and echocardiographic correlates. Scandinavian Cardiovascular Journal: SCJ. 2015;49:213-219
  3. Spiliopoulos K, Giamouzis G, Haschemi A, Karangelis D, Antonopoulos N, Fink G, Kemkes BM, Gansera B. Surgical management of infective endocarditis: Early and long-term mortality analysis. Singlecenter experience and brief literature review. Hellenic journal of cardiology : HJC

= Hellenike kardiologike epitheorese. 2014;55:462-474

  1. Gialafos E, Triposkiadis F, Kouranos V, Rapti A, Kosmas I, Manali E, Giamouzis G, Elezoglou A, Peros I, Anagnostopoulou O, Koulouris N, Gazouli M. Relationship between tumor necrosis factor-alpha (tnfa) gene polymorphisms and cardiac sarcoidosis. In vivo. 2014;28:1125-1129
  2. Karangelis D, Daskalopoulos M, Giamouzis G, Koufakis T, Fragoulis S, Papadakis E, Kalafati G, Tsilimingas N. Acute aortic dissection is independent of weather conditions but statistically correlates with day of the week. Journal of emergencies, trauma, and shock. 2014;7:244-246
  3. Giallafos I, Triposkiadis F, Oikonomou E, Giamouzis G, Aggeli K, Konstantopoulou P, Kouranos V, Mavrikakis M, Giallafos J, Stefanadis C, Sfikakis PP. Incident atrial fibrillation in systemic sclerosis: The predictive role of b-type natriuretic peptide. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese. 2014;55:313-321
  4. Samaras A, Tsarouhas K, Paschalidis E, Giamouzis G, Triposkiadis F, Tsitsimpikou C, Becker AT, Goutzourelas N, Kouretas D. Effect of a special carbohydrate-protein bar and tomato juice supplementation on oxidative stress markers and vascular endothelial dynamics in ultra-marathon runners. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2014;69:231-236
  5. Giamouzis G, Triposkiadis F, Georgiopoulou VV, Farmakis D, Westermann D, Skoularigis J. Heart failure 2013. Cardiology research and practice. 2013;2013:342316
  6. Triposkiadis FK, Butler J, Karayannis G, Starling RC, Filippatos G, Wolski K, Parissis J, Parisis C, Rovithis D, Koutrakis K, Skoularigis J, Antoniou CK, Chrysohoou C, Pitsavos C, Stefanadis C, Nastas J, Tsaknakis T, Mantziari L, Giannakoulas G, Karvounis H, Kalogeropoulos AP, Giamouzis G. Efficacy and safety of high dose versus low dose furosemide with or without

dopamine infusion: The dopamine in acute decompensated heart failure ii (dad-hf ii) trial.

International journal of cardiology. 2014;172:115-121

  1. Karayannis G, Triposkiadis F, Skoularigis J, Georgoulias P, Butler J, Giamouzis G. The emerging role of galectin-3 and st2 in heart failure: Practical considerations and pitfalls using novel biomarkers. Current heart failure reports. 2013;10:441-449
  2. Giamouzis G, Kalogeropoulos AP, Butler J, Karayannis G, Georgiopoulou VV, Skoularigis J, Triposkiadis F. Epidemiology and importance of renal dysfunction in heart failure patients. Current heart failure reports. 2013;10:411-420
  3. Giamouzis G, Giannakoulas G, Butler J, Elefteriades JA, Tschope C, Triposkiadis F. Heart failure 2012. Cardiology research and practice. 2012;2012:126324
  4. Cole RT, Masoumi A, Triposkiadis F, Giamouzis G, Georgiopoulou V, Kalogeropoulos A, Butler J. Renal dysfunction in heart failure. The Medical clinics of North America. 2012;96:955- 974
  5. Spiliopoulos K, Giamouzis G, Karayannis G, Karangelis D, Koutsias S, Kalogeropoulos A, Georgiopoulou V, Skoularigis J, Butler J, Triposkiadis F. Current status of mechanical circulatory support: A systematic review. Cardiology research and practice. 2012;2012:574198
  6. Marti CN, Georgiopoulou VV, Giamouzis G, Cole RT, Deka A, Tang WH, Dunbar SB, Smith AL, Kalogeropoulos AP, Butler J. Patient-reported selective adherence to heart failure self-care recommendations: A prospective cohort study: The atlanta cardiomyopathy consortium. Congestive heart failure. 2013;19:16-24
  7. Karayannis G, Giamouzis G, Cokkinos DV, Skoularigis J, Triposkiadis F. Diabetic cardiovascular autonomic neuropathy: Clinical implications. Expert review of cardiovascular therapy. 2012;10:747-765
  8. Mastrogiannis D, Giamouzis G, Dardiotis E, Karayannis G, Chroub-Papavaiou A, Kremeti D, Spiliopoulos K, Georgoulias P, Koutsias S, Bonotis K, Mantzorou M, Skoularigis J, Hadjigeorgiou GM, Butler J, Triposkiadis F. Depression in patients with cardiovascular disease. Cardiology research and practice. 2012;2012:794762
  9. Dardiotis E, Giamouzis G, Mastrogiannis D, Vogiatzi C, Skoularigis J, Triposkiadis F, Hadjigeorgiou GM. Cognitive impairment in heart failure. Cardiology research and practice. 2012;2012:595821
  10. Giamouzis G, Mastrogiannis D, Koutrakis K, Karayannis G, Parisis C, Rountas C, Adreanides E, Dafoulas GE, Stafylas PC, Skoularigis J, Giacomelli S, Olivari Z, Triposkiadis F. Telemonitoring

in chronic heart failure: A systematic review. Cardiology research and practice. 2012;2012:410820

  1. Karayannis G, Giamouzis G, Tziolas N, Georgoulias P, Skoularigis J, Mikhailidis DP, Triposkiadis F. Association between epicardial fat thickness and weight homeostasis hormones in patients with noncachectic heart failure. Angiology. 2013;64:173-180
  2. Triposkiadis F, Starling RC, Boudoulas H, Giamouzis G, Butler J. The cardiorenal syndrome in heart failure: Cardiac? Renal? Syndrome? Heart failure reviews. 2012;17:355-366
  3. Apostolou P, Tsantsaridou A, Papasotiriou I, Toloudi M, Chatziioannou M, Giamouzis G. Bacterial and fungal microflora in surgically removed lung cancer samples. Journal of cardiothoracic surgery. 2011;6:137
  4. Giamouzis G, Butler J, Triposkiadis F. Renal function in advanced heart failure. Congestive heart failure. 2011;17:180-188
  5. Giamouzis G, Triposkiadis F, Butler J, Westermann D, Giannakoulas G. Heart failure.

Cardiology research and practice. 2011;2011:159608

  1. Karayannis G, Giamouzis G, Alexandridis E, Kamvrogiannis P, Butler J, Skoularigis J, Triposkiadis F. Prevalence of impaired coronary flow reserve and its association with left ventricular diastolic function in asymptomatic individuals with major cardiovascular risk factors. European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. 2011;18:326-333
  2. Triposkiadis F, Giamouzis G, Butler J. The importance of managing diabetes correctly to prevent heart failure. Expert review of cardiovascular therapy. 2011;9:257-259
  3. Giamouzis G, Kalogeropoulos A, Georgiopoulou V, Laskar S, Smith AL, Dunbar S, Triposkiadis F, Butler J. Hospitalization epidemic in patients with heart failure: Risk factors, risk prediction, knowledge gaps, and future directions. Journal of cardiac failure. 2011;17:54-75
  4. Malik AS, Giamouzis G, Georgiopoulou VV, Fike LV, Kalogeropoulos AP, Norton CR, Sorescu D, Azim S, Laskar SR, Smith AL, Dunbar SB, Butler J. Patient perception versus medical record entry of health-related conditions among patients with heart failure. The American journal of cardiology. 2011;107:569-572
  5. Gregory Giamouzis, Dimitrios Pappas, Nikolaos Simeonidis, Evangelos Stathogiannis, Filippos Triposkiadis, and George N. Koukoulis, “Acute Experimental Hyperthyroidism Does Not Affect Basal and Volume-Induced Atrial Natriuretic Peptide Secretion in Healthy Subjects,” Cardiology Research and Practice, vol. 2011, Article ID 381865, 6 pages, 2011. doi:10.4061/2011/381865
  6. Giamouzis G, Butler J, Starling RC, Karayannis G, Nastas J, Parisis C, Rovithis D, Economou D, Savvatis K, Kirlidis T, Tsaknakis T, Skoularigis J, Westermann D, Tschope C, Triposkiadis F. Impact of dopamine infusion on renal function in hospitalized heart failure patients: Results of the dopamine in acute decompensated heart failure (dad-hf) trial. Journal of cardiac failure. 2010;16:922-930
  7. Karayannis G, Tsezou A, Giannatou E, Papanikolaou V, Giamouzis G, Triposkiadis F. Polymorphisms of renin-angiotensin system and natriuretic peptide receptor a genes in patients of greek origin with a history of myocardial infarction. Angiology. 2010;61:737-743
  8. Adreanides E, Giamouzis G, Pavlides G. High-output cardiomyopathy regression following percutaneous closure of left internal mammary and subclavian to pulmonary artery fistulae. Circulation journal : official journal of the Japanese Circulation Society. 2010;74:1260-1261
  9. Giamouzis G, Triposkiadis F, Butler J. Metformin use in patients with diabetes mellitus and heart failure: Friend or foe? Journal of cardiac failure. 2010;16:207-210
  10. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. Journal of the American College of Cardiology. 2009;54:1747-1762
  11. Georgiopoulou VV, Kalogeropoulos AP, Giamouzis G, Agha SA, Rashad MA, Waheed S, Laskar S, Smith AL, Butler J. Digoxin therapy does not improve outcomes in patients with advanced heart failure on contemporary medical therapy. Circulation. Heart failure. 2009;2:90-97
  12. Agha SA, Kalogeropoulos AP, Shih J, Georgiopoulou VV, Giamouzis G, Anarado P, Mangalat D, Hussain I, Book W, Laskar S, Smith AL, Martin R, Butler J. Echocardiography and risk prediction in advanced heart failure: Incremental value over clinical markers. Journal of cardiac failure. 2009;15:586-592
  13. Kalogeropoulos AP, Georgiopoulou VV, Giamouzis G, Pernetz MA, Anadiotis A, McConnell M, Lerakis S, Butler J, Book WM, Martin RP. Myocardial deformation imaging of the systemic right ventricle by two-dimensional strain echocardiography in patients with d-transposition of the great arteries. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese. 2009;50:275- 282
  14. Manginas A, Tsiavou A, Sfyrakis P, Giamouzis G, Tsourelis L, Leontiadis E, Degiannis D, Cokkinos DV, Alivizatos PA. Increased number of circulating progenitor cells after implantation of ventricular assist devices. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2009;28:710-717
  15. Mujib M, Giamouzis G, Agha SA, Aban I, Sathiakumar N, Ekundayo OJ, Zamrini E, Allman RM, Butler J, Ahmed A. Epidemiology of stroke in chronic heart failure patients with normal

sinus rhythm: Findings from the dig stroke sub-study. International journal of cardiology. 2010;144:389-393

  1. Giamouzis G, Kalogeropoulos AP, Georgiopoulou VV, Agha SA, Rashad MA, Laskar SR, Smith AL, Butler J. Incremental value of renal function in risk prediction with the seattle heart failure model. American heart journal. 2009;157:299-305
  2. Kalogeropoulos AP, Georgiopoulou VV, Giamouzis G, Smith AL, Agha SA, Waheed S, Laskar S, Puskas J, Dunbar S, Vega D, Levy WC, Butler J. Utility of the seattle heart failure model in patients with advanced heart failure. Journal of the American College of Cardiology. 2009;53:334-342
  3. Giamouzis G, Agha SA, Ekundayo OJ, Aban I, Love TE, Daniel C, Butler J, Ahmed A. Incident coronary revascularization and subsequent mortality in chronic heart failure: A propensity- matched study. International journal of cardiology. 2010;140:55-59
  4. Manginas A, Tsiavou A, Chaidaroglou A, Giamouzis G, Degiannis D, Panagiotakos D, Cokkinos DV. Inflammatory cytokine gene variants in coronary artery disease patients in greece. Coronary artery disease. 2008;19:575-582
  5. Gambassi G, Agha SA, Sui X, Yancy CW, Butler J, Giamouzis G, Love TE, Ahmed A. Race and the natural history of chronic heart failure: A propensity-matched study. Journal of cardiac failure. 2008;14:373-378
  6. Giamouzis G, Giannakoulas G, Tsarpalis K, Agha SA, Georgiopoulou V, Kalogeropoulos A, Karvounis H, Butler J. Natriuretic peptide-guided levosimendan therapy for heart failure: A promising new approach. International journal of cardiology. 2008;128:91-93
  7. Giamouzis G, Sui X, Love TE, Butler J, Young JB, Ahmed A. A propensity-matched study of the association of cardiothoracic ratio with morbidity and mortality in chronic heart failure. The American journal of cardiology. 2008;101:343-347
  8. Mavrogeni S, Giamouzis G, Papadopoulou E, Thomopoulou S, Dritsas A, Athanasopoulos G, Adreanides E, Vassiliadis I, Spargias K, Panagiotakos D, Cokkinos DV. A 6-month follow-up of intermittent levosimendan administration effect on systolic function, specific activity questionnaire, and arrhythmia in advanced heart failure. Journal of cardiac failure. 2007;13:556- 559
  9. Butler J, Giamouzis G, Giannakoulas G. A struggle to survive: To abandon or not to abandon levosimendan? Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy. 2007;21:401-402
  10. Giamouzis G, Butler J. Relationship between heart failure and lipids: The paradigm continues to evolve. Journal of cardiac failure. 2007;13:254-258
  11. Triposkiadis F, Giamouzis G, Kelepeshis G, Sitafidis G, Skoularigis J, Demopoulos V. Acute hemodynamic effects of moderate doses of nebivolol versus metoprolol in patients with systolic heart failure. International journal of clinical pharmacology and therapeutics. 2007;45:71-77
  12. Spargias K, Adreanides E, Giamouzis G, Karagiannis S, Gouziouta A, Manginas A, Voudris V, Pavlides G, Cokkinos DV. Iloprost for prevention of contrast-mediated nephropathy in high-risk patients undergoing a coronary procedure. Results of a randomized pilot study. European journal of clinical pharmacology. 2006;62:589-595
  13. Mavrogeni S, Giamouzis G, Pavlides G, Cokkinos DV. Grossly dilated vein graft evaluated by x- ray coronary angiography and contrast-enhanced magnetic resonance angiography. Hellenic journal of cardiology. 2006;47:44-45

R E V E W E R I N I N T E R N A T I O N A L J O U R N A L S

  1. American Journal of Cardiology
  2. American Heart Journal
  3. International Journal of Cardiology
  4. Hellenic Journal of Cardiology
  5. Heart
  6. Journal of Cardiac Failure
  7. European Journal of Heart Failure
  8. Cardiology Research and Practice
  9. Medicine
  10. Congestive Heart Failure

B O O K C H A P T E R S

  1. Giamouzis G, Skoularigis J, Triposkiadis F. “Definition, Epidemiology, Economic Cost and Health Policies”. In “Frontiers in heart failure – Molecular imaging”. Editor: Georgoulias P. 1st Edition, 2015.
  2. Giamouzis G, Filippatos G, Parisis J, Triposkiadis F. “Heart Failure”. In “Cardiology”, Triposkiadis F, 2nd Edition, Lagos Editions, 2015
  3. Triposkiadis F, Giamouzis G, Skoularigis J. “Aetiology and Pathophysiology: Cellular and Molecular Alterations of Heart Failure”. In “Frontiers in heart failure – Molecular imaging”. Editor: Georgoulias P. 1st Edition, 2015.
  4. Marti CN, Cole RT, Giamouzis G, Butler J. “Digoxin, Diuretics, and Vasodilators in Patients with Heart Failure”. In R.R Balliga and G.J. Haas (eds), “Management of Heart Failure: Volume 1: Medical”. 3rd Edition, Springer-Verlag London 2015.
  5. Skoularigis J, Xanthopoulos A, Giamouzis G, Triposkiadis F. “Clinical Manifestations, Coexisting Diseases, Patients’ Investigation & Prognostication”. In “Frontiers in heart failure – Molecular imaging”. Editor: Georgoulias P. 1st Edition, 2015.
  6. Louridas G, Giamouzis G, Sitafidis G, Triposkiadis F. “Pathophysiology of atherothrombosis in diabetes mellitus”. In “Diabetes, heart, vessels”. Triposkiadis F, Louridas G. 1st Edition, Lagos Editions, 2010.
  7. Kotidis C, Giamouzis G, Koukoulis GN, Triposkiadis F. “Diabetic cardiovascular autonomic neuropathy”. In “Diabetes, heart, vessels”. Triposkiadis F, Louridas G. 1st Edition, Lagos Editions, 2010.
  8. Koukoulis GN, Giamouzis G, Demopoulos V, Triposkiadis F. “Diabetic cardiomyopathy”. In “Diabetes, heart, vessels”. Triposkiadis F, Louridas G. 1st Edition, Lagos Editions, 2010.
  9. Giamouzis G, Butler J, Laskar SR. “Congestive Heart Failure”. British Medical Journal Association electronic publication “Point of Care”. Available on-line and on PDA: June 2008
  10. Giamouzis G, Agha SA, Butler J. “Relationship between heart failure and lipids: the paradigm continues to evolve”. In Balliga, “Chronic Heart Failure”. 2nd Edition, Springer, 2008.
  11. Giamouzis G, Laskar SR, Smith AL. “Heart Failure Therapy: the Renin-Angiotensin- Aldosterone System”. Journal of Heart and Lung Transplantation monograph series, 2008

T R A I N I N G C O U R S E S

  • August 2009

Experimental heart failure models.

Organizer: Heart Clinic, Charite University, Berlin, Germany

  • November 2007

Treatment of Mixed Dislipidemia

Organizer: Albert Einstein College of Medicine.

Endorsed by the American Heart Association, Orlando, FL, USA

  • April 2007

Arrhythmia Management

Organizer: Emory University School of Medicine, Atlanta, GA, USA

  • January 2005

Advanced Life Support (ALS) provider course. Organizer: European Resuscitation Council. Hosted by Hellenic Cardiological Society, Athens, Greece

  • November 2004

Basic Life Support (BLS) Provider Course. Organizer: European Resuscitation Council. Hosted by Hellenic Cardiological Society, Athens, Greece

  • November 2004

Automatic External Defibrillator (AED) provider course. Organizer: European Resuscitation Council. Hosted by Hellenic Cardiological Society, Athens, Greece

F O R E I G N L A N G U A G E S

  • English

Proficiency in English (awarding body: the University of Michigan)

First Certificate in English (awarding body: the University of Cambridge)

  • French

Moderate (no certificate)

  • Italian

Moderate (no certificate)

O T H E R I N F O R M A T I O N

    1. Classic and Modern Piano ( Diploma of Hellenic School of Music )
    2. Excellent command of computer software (Word, Excel, Power Point, Access, Outlook, SPSS, search engines and internet databases)